US Patent Issued to The Florida International University Board of Trustees on Sept. 16 for "Arsinothricin and methods of treating infections using arsinothricin" (Florida, Georgia Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,932, issued on Sept. 16, was assigned to The Florida International University Board of Trustees (Miami).

"Arsinothricin and methods of treating infections using arsinothricin" was invented by Barry Philip Rosen (Boynton Beach, Fla.) and Masafumi Yoshinaga (Kennesaw, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Certain embodiments of the invention pertain to a method of treating an infection in a subject caused by an infectious agent other than Escherichia coli, the method comprising administering to the subject arsinothricin or a salt thereof. The infectious agent other than E. coli can be a bacterium, protozoan, helminth, archaebacterium, or...